Kronox Lab Sciences Ltd
NSE: KRONOX | BSE: 544187
₹134.57
₹2.92
(2.22%)
As on 12-Jun-2026IST
Market cap
₹501 Cr
Revenue (TTM)
₹101 Cr
P/E Ratio
18.1
P/B Ratio
4.3
Div. Yield
0.4 %
Quality Score
6/10
Growth Score
4/10
Valuation Score
6/10
Momentum Score
5/10
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
₹28 Cr
-
ROE
32.6 %
-
ROCE
43.8 %
-
Industry P/E
38.13
-
EV/EBITDA
11.5
-
Debt to Equity
0
-
Book Value
₹31.3
-
EPS
₹7.4
-
Face value
10
-
Shares outstanding
37,104,000
5 Years Aggregate
CFO
₹88.11 Cr
EBITDA
₹117.65 Cr
Net Profit
₹86.58 Cr
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Kronox Lab Sciences
| -3.7 | -3.5 | 20.3 | -18.4 | -- | -- | -- |
|
BSE Commodities
| 6.1 | -1.4 | 7.2 | 9.1 | 16.2 | 10.1 | 15.4 |
|
Company
|
2025
|
|---|---|
|
Kronox Lab Sciences
| -31.8 |
|
BSE Small Cap
| -6.6 |
|
BSE Commodities
| 12.5 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Peers
View DetailsCompany |
Price (₹) | Market Cap (₹ Cr) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Kronox Lab Sciences
|
134.6 | 500.7 | 101.2 | 27.6 | 31.7 | 25.3 | 18.1 | 4.3 |
| 440.6 | 15,974.7 | 8,302.0 | 419.0 | 8.3 | 7.1 | 38.1 | 2.7 | |
| 1,142.9 | 15,183.2 | 1,153.5 | 219.5 | 25.6 | 9.5 | 69.2 | 6.2 | |
| 1,250.3 | 14,206.0 | 2,365.5 | 222.2 | 16.3 | 5.2 | 83.5 | 4.3 | |
| 1,669.9 | 22,779.0 | 7,887.1 | 550.7 | 9.6 | 9.9 | 41.4 | 3.9 | |
| 4,724.7 | 14,483.6 | 2,365.8 | 420.2 | 18.0 | 16 | 34.7 | 5.4 | |
| 6,131.5 | 14,247.3 | 2,120.1 | 338.2 | 18.4 | 13.1 | 42.1 | 5.4 | |
| 623.4 | 9,928.8 | 4,388.3 | 278.1 | 8.9 | 9.3 | 35.7 | 3.2 | |
| 3,444.3 | 13,441.3 | 2,563.7 | 316.7 | 19.6 | 24.7 | 41 | 9.5 | |
| 1,303.2 | 13,511.3 | 2,226.9 | 443.8 | 24.4 | 14.6 | 30.4 | 4.3 |
Shareholding Pattern
View DetailsNews & Analysis
All News
4 min read•By Hemkesh Khattar
About Kronox Lab Sciences
--
-
Incorporated
2008
-
Chairman
Jogindersingh Jaswal
-
Managing Director
Jogindersingh Jaswal
-
Headquarters
Vadodara, Gujarat
-
Website
Looking for more details about Kronox Lab Sciences Ltd’s IPO? Explore our IPO Details page.
Value Research Ratings
Our rating system has guided millions of investors in the past 20 years.
Annual Reports
Announcements
View AnnouncementsNo News & Announcements are available.
FAQs for Kronox Lab Sciences
What is the current share price of Kronox Lab Sciences Ltd Today?
The share price of Kronox Lab Sciences Ltd is ₹134.57 (NSE) and ₹134.95 (BSE) as of 12-Jun-2026 IST. Kronox Lab Sciences Ltd has given a return of -18.45% in the last 1 years.
What is the current PB & PE ratio of Kronox Lab Sciences Ltd?
The P/E ratio of Kronox Lab Sciences Ltd is 18.10 times as on 12-Jun-2026, a 53 discount to its peers’ median range of 38.13 times.
The P/B ratio of Kronox Lab Sciences Ltd is 4.31 times as on 12-Jun-2026, a 70 premium to its peers’ median range of 2.54 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2025
|
20.96
|
5.92
|
|
2024
|
0.00
|
0.00
|
|
2023
|
0.00
|
0.00
|
|
2022
|
0.00
|
0.00
|
|
2021
|
0.00
|
0.00
|
What is the 52 Week High and Low of Kronox Lab Sciences Ltd?
The 52-week high and low of Kronox Lab Sciences Ltd are Rs 207.49 and Rs 96.00 as of 13-Jun-2026.
What is the market cap of Kronox Lab Sciences Ltd?
Kronox Lab Sciences Ltd has a market capitalisation of ₹ 501 Cr as on 12-Jun-2026. As per SEBI classification, it is a Small Cap company.
Should I invest in Kronox Lab Sciences Ltd?
Before investing in Kronox Lab Sciences Ltd, assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.